University of Proportion of Pelvic Inflammatory Disease caused by Chlamydia trachomatis: consistent picture from different methods
暂无分享,去创建一个
[1] A. Menon-Johansson,et al. Sexually transmitted infections in primary care , 2016 .
[2] M. Price,et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. , 2016, Health technology assessment.
[3] G. Garnett,et al. Heterogeneity in Risk of Pelvic Inflammatory Diseases After Chlamydia Infection: A Population-Based Study in Manitoba, Canada , 2014, The Journal of infectious diseases.
[4] J. Ravel,et al. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. , 2014, Vaccine.
[5] E. Adams,et al. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.
[6] D. De Angelis,et al. Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model , 2013, American journal of epidemiology.
[7] T. Darville,et al. Does Bacterial Vaginosis Cause Pelvic Inflammatory Disease? , 2013, Sexually transmitted diseases.
[8] S. Mehta. Systematic Review of Randomized Trials of Treatment of Male Sexual Partners for Improved Bacteria Vaginosis Outcomes in Women , 2012, Sexually transmitted diseases.
[9] K. Soldan,et al. Estimation of the Rate of Pelvic Inflammatory Disease Diagnoses: Trends in England, 2000–2008 , 2011, Sexually transmitted diseases.
[10] N. Low,et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. , 2010, The Journal of infectious diseases.
[11] N. Low,et al. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? , 2010, The Journal of infectious diseases.
[12] S. Kerry,et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial , 2010, BMJ : British Medical Journal.
[13] B. Thomas,et al. Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease , 2009, International journal of STD & AIDS.
[14] F. Cecinato,et al. Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women: correlation with the presence of serological markers for this infection. , 2008, The new microbiologica.
[15] L. Nilas,et al. European guideline for the management of pelvic inflammatory disease , 2007, International journal of STD & AIDS.
[16] J. Stephenson,et al. Risk factors associated with pelvic inflammatory disease , 2006, Sexually Transmitted Infections.
[17] J. Ross. Pelvic inflammatory disease. , 2005, Clinical evidence.
[18] G. Burstein,et al. Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.
[19] K. Thomas,et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease , 2003, Journal of clinical pathology.
[20] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[21] J. Lave,et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. , 2002, American journal of obstetrics and gynecology.
[22] F. Olesen,et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[24] J. Stephenson,et al. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? , 2000, Sexually transmitted infections.
[25] J. Paavonen,et al. Chlamydia trachomatis: impact on human reproduction. , 1999, Human reproduction update.
[26] Andrew Gelman,et al. General methods for monitoring convergence of iterative simulations , 1998 .
[27] Arthur P. Dempster,et al. The direct use of likelihood for significance testing , 1997, Stat. Comput..
[28] K. Holmes,et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. , 1996, The New England journal of medicine.
[29] P. Wølner-Hanssen,et al. Silent pelvic inflammatory disease: is it overstated? , 1995, Obstetrics and gynecology.
[30] G. Ridgway,et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort , 1995, British journal of obstetrics and gynaecology.
[31] S. Thompson,et al. Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.
[32] S. Cox,et al. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. , 1991, American journal of obstetrics and gynecology.
[33] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.